Le site du DES d'oncologie de Toulouse
Crédits

Site développé par Ilfad Blazevic

RESUME PORTEC 2
Corentin Pasquier24/01/2022
Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial
maeva bonneau20/01/2022
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
maeva bonneau20/01/2022
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
maeva bonneau20/01/2022
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement
Guillaume Roces27/12/2021
Tout afficher
Se connecter

Mot de passe oublié ?

Inscription

Agenda
28
jan
Réunion Solstice
Cours de DES
01
fé
Réunion Formation Sandoz
Autre
11
fé
cours de DES février
Cours de DES
28
fé
Oncolunch
Rencontres
01
mar
Echange de pratiques
Rencontres